Zhiguang Fu
- Topics
- Signaling Pathways in Disease (6 papers)Galectins and Cancer Biology (6 papers)Cancer Cells and Metastasis (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhiguang Fu
17 papers receiving 570 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 419
- Immunology 145
- Cancer Research 119
- Oncology 97
- Biomedical Engineering 64
Countries citing papers authored by Zhiguang Fu
This map shows the geographic impact of Zhiguang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiguang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiguang Fu more than expected).
Fields of papers citing papers by Zhiguang Fu
This network shows the impact of papers produced by Zhiguang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiguang Fu. The network helps show where Zhiguang Fu may publish in the future.
Co-authorship network of co-authors of Zhiguang Fu
This figure shows the co-authorship network connecting the top 25 collaborators of Zhiguang Fu. A scholar is included among the top collaborators of Zhiguang Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiguang Fu. Zhiguang Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 136 | |
| 6 | Triptolide reduces proliferation and enhances apoptosis in drug-resistant human oral cancer cells. | 3 |
| 7 | 5 | |
| 8 | 45 | |
| 9 | 36 | |
| 10 | 23 | |
| 11 | 56 | |
| 12 | 30 | |
| 13 | Cytoplasmic EpCAM over-expression is associated with favorable clinical outcomes in pancreatic cancer patients with Hepatitis B virus negative infection. | 13 |
| 14 | Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice. | 94 |
| 15 | 16 | |
| 16 | 40 | |
| 17 | 60 |
About Zhiguang Fu
Zhiguang Fu is a scholar working on Immunology, Cancer Research and Molecular Biology, having authored 17 papers that have together received 571 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (6 papers), Galectins and Cancer Biology (6 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (119 citations), Immunology (145 citations) and Molecular Biology (419 citations). Zhiguang Fu has collaborated with scholars based in China and United States. Frequent co-authors include Zhi‐Nan Chen, Jian‐Li Jiang, Bo Wu, Jianghua Li, Jing Lin, Zhenyu Liu, Ning Wen, Juan Xu, Lisheng Zhao and Shuo Yang. Their work appears in journals such as Scientific Reports, Small and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.